Detection of myocardial ischemia by CT perfusion imaging in comparison with N-13 ammonia PET - Myocardial CT perfusion versus N-13 ammonia PET

Tokyo Women's Medical University0 sites20 target enrollmentDecember 5, 2014

Conditionscoronary artery disease

Overview

Phase: 未知
Intervention: Not specified
Conditions: coronary artery disease
Sponsor: Tokyo Women's Medical University
Enrollment: 20
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

December 5, 2014

End Date

October 31, 2015

Last Updated

2 years ago

Study Type

Interventional,observational

Sex

All

Investigators

Sponsor

Tokyo Women's Medical University

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. Body weight \>75kg 2\. Elevated serum creatinine (\>1\.5 mg/dL) or calculated creatinine clearance of \<60 mL/min 3\. History of allergic reaction to iodinated contrast media, History of contrast\-induced nephropathy 4\. Atrial fibrillation or uncontrolled tachyarrhythmia 5\. Advanced atrioventricular block (second\- or third\-degree heart block) 6\. Evidence of acute coronary syndrome 7\. Known or suspected moderate or severe aortic stenosis 8\. Evidence of severe symptomatic heart failure (New York Heart Association class III or IV) 9\. Previous coronary artery bypass or other cardiac surgery 10\. Coronary artery intervention within the past 6 months 11\. Contraindications to vasodilatory stress (systolic blood pressure \<90, recent use of dipyridamole\- and dipyridamole\-containing medications, recent use of methylxanthines, such as aminophylline and caffeine) 12\. Profound sinus bradycardia (fewer than 40 beats per minute) 13\. Known or suspected intolerance or contraindication to beta\-blockers (including known allergy to betablockers, history of moderate to severe bronchospastic lung disease, including moderate to severe asthma, severe pulmonary disease with the use of inhaled bronchodilator over the past year) 14\. Presence of intracardiac devices, such as intracardiac defibrillator or metallic implants within the imaging field of view 15\. History of high radiation exposure (\>2 nuclear or multidetector CT studies) in the 1 month before consent 16\. The presence of any other history or condition that the investigator judged to be a significant reason for exclusion